IntegriChain Acquires Cumberland's Life Sciences Division

Apotex Acquires Cumberland Pharmaceuticals' U.S. Branded Portfolio for $100 Million

April 23, 2026

Pharmaceuticals

Apotex entered into an agreement with Cumberland Pharmaceuticals to integrate Cumberland’s U.S. branded pharmaceutical business into Apotex. Under the terms, Apotex will acquire Cumberland’s line of branded pharmaceuticals for $100 million in cash, while Cumberland retains its pipeline candidates (including ifetroban) and its majority ownership in Cumberland Emerging Technologies Inc.

IntegriChain Acquires Federal Compliance Solutions

July 9, 2024

Healthcare Services

IntegriChain has acquired Federal Compliance Solutions (FCS), a life‑sciences advisory and managed‑services firm focused on government pricing, contracting, and gross‑to‑net. The deal expands IntegriChain’s outsourcing and advisory capabilities, bringing FCS’s team of more than 60 professionals into IntegriChain’s ~750‑person global organization to deepen contracts & pricing and gross‑to‑net offerings for pharmaceutical manufacturers.

IntegriChain Acquires BridgeView Data Solutions

June 18, 2024

Data & Analytics

IntegriChain has acquired the commercial data warehouse and data aggregation assets (DataBridge) of BridgeView Life Sciences LLC, integrating BridgeView's AI-assisted data exploration and field intelligence into IntegriChain’s ICyte platform. The deal expands IntegriChain's commercial data capabilities for pharmaceutical manufacturers and is the company's sixth acquisition and first since partnering with private equity backer Nordic Capital.

Nordic Capital Acquires Majority Stake in IntegriChain from Accel-KKR

November 8, 2023

Cloud & SaaS

Nordic Capital has agreed to acquire a majority share in IntegriChain, a Philadelphia-based provider of a data-driven commercialization and market-access platform for the pharmaceutical industry, from Accel-KKR. The terms were not disclosed; closing is expected before year-end and is subject to customary regulatory and closing conditions.

IntegriChain Acquires Blue Fin Group

January 20, 2022

Consulting

IntegriChain has acquired Blue Fin Group, a life-sciences focused management consulting firm that specializes in market access, commercialization strategy, and patient services. The deal brings Blue Fin's team of consultants into IntegriChain as an independent division to combine IntegriChain's ICyte data and application platform with Blue Fin's commercialization expertise, expanding end-to-end therapy launch and market access capabilities.

Tegria Acquires Cumberland

March 16, 2021

Healthcare Services

Tegria, a healthcare technology and services company launched by Providence, has acquired Cumberland, a Franklin, Tennessee–based healthcare consulting and managed services firm with more than 250 employees. The acquisition expands Tegria's consulting capabilities for payer organizations, strengthens its managed services for providers, and will have Cumberland operate as an independent business unit within Tegria's consulting and technology services group.